Article
A composite score based on immune-related gene prognostic index and m6A risk score of head and neck squamous cell carcinoma
2022-08-26
Abstract excerpt
<h4>Background: </h4> Immunotherapy has been demonstrated favorable in head and neck squamous cell carcinoma (HNSCC). Studies indicated that immune-related gene prognostic index (IRGPI) was a robust signature, and N6-methyladenosine (m 6 A) methylation had a significant impact on the tumor immune microenvironment (TIME) and immunotherapy of HNSCC. Thus, combining IRGPI with m 6 A status should offer a better predi...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 90f5c7d8-5bc5-5c37-b3c8-46ac814d0018
- DOI
- 10.21203/rs.3.rs-1987322/v1
